A dengue fever vaccine has been developed in Russia. Clinical trials will begin soon. The creation of the drug was announced by the head of the FMBA, Veronika Skvortsova, at a meeting of the department.
A recombinant genetic engineering vaccine against dengue fever has been developed, and its clinical trials are beginning.
According to the head of the agency, the development was carried out at the request of the President of the Republic of Nicaragua, Daniel Ortega.
Dengue fever is a viral disease that is transmitted through mosquito bites. It can cause high fever, severe pain, and serious complications.
The disease is especially active in warm and humid climates. Dengue fever is widespread in tropical and subtropical regions of the world — primarily in countries in Southeast and South Asia, Latin America, Africa, and Oceania.
Read more on the topic:
17 Apr 08:46
News
Medicine of the Future: RAS Scientists Create Graphene Sensor on Mask That Detects Diseases by Breathing
The device detects traces of acetone and other markers of chronic diseases
16 Apr 07:21
News
Pinky Finger Instead of Remote Control: Rostec Creates Unique Prosthesis for Teenager with Complex Hand Pathology
The microprocessor-equipped device was adapted for a rare congenital anomaly
14 Apr 12:01
News
Athletes will be monitored by digital systems: a unified health database for athletes will be created in Russia
It will include medical data, examinations, and even physical fitness indicators - the platform will be launched as early as 2026
14 Apr 11:29
News
A new vaccine for colorectal cancer has been approved for use in Russia: the drug forces the immune system to attack the tumor
The personalized mRNA drug is tailored to the specific patient
10 Apr 12:34
News
NSU Scientists Discover New Polymorphic Phase of Antidiabetic Drug Using Synchrotron Radiation
Under high pressure, the substance transitions into an intermediate form that could become the basis for more effective drugs
